195 related articles for article (PubMed ID: 21145280)
1. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.
Overeem S; van Nues SJ; van der Zande WL; Donjacour CE; van Mierlo P; Lammers GJ
Sleep Med; 2011 Jan; 12(1):12-8. PubMed ID: 21145280
[TBL] [Abstract][Full Text] [Related]
2. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
3. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
5. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
6. Narcolepsy-cataplexy associated with precocious puberty.
Plazzi G; Parmeggiani A; Mignot E; Lin L; Scano MC; Posar A; Bernardi F; Lodi R; Tonon C; Barbiroli B; Montagna P; Cicognani A
Neurology; 2006 May; 66(10):1577-9. PubMed ID: 16717224
[TBL] [Abstract][Full Text] [Related]
7. Emerging treatments for narcolepsy and its related disorders.
Nishino S; Okuro M
Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
Heier MS; Jansson TS; Gautvik KM
J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
[TBL] [Abstract][Full Text] [Related]
9. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
10. Cortical morphometry in narcolepsy with cataplexy.
Schaer M; Poryazova R; Schwartz S; Bassetti CL; Baumann CR
J Sleep Res; 2012 Oct; 21(5):487-94. PubMed ID: 22309460
[TBL] [Abstract][Full Text] [Related]
11. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
[TBL] [Abstract][Full Text] [Related]
12. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
13. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons.
Knudsen S; Mikkelsen JD; Jennum P
Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865
[TBL] [Abstract][Full Text] [Related]
14. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
[TBL] [Abstract][Full Text] [Related]
15. An immersive simulation system for provoking and analyzing cataplexy.
Augustine K; Cameron B; Camp J; Krahn L; Robb R
Stud Health Technol Inform; 2002; 85():31-7. PubMed ID: 15458056
[TBL] [Abstract][Full Text] [Related]
16. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy.
Knudsen S; Mikkelsen JD; Bang B; Gammeltoft S; Jennum PJ
Neuropediatrics; 2010 Oct; 41(5):217-22. PubMed ID: 21210337
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
[TBL] [Abstract][Full Text] [Related]
19. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
Dauvilliers Y; Abril B; Mas E; Michel F; Tafti M
Neurology; 2009 Oct; 73(16):1333-4. PubMed ID: 19841387
[No Abstract] [Full Text] [Related]
20. Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders?
Flosnik DL; Cortese BM; Uhde TW
J Clin Psychiatry; 2009 Jun; 70(6):810-6. PubMed ID: 19422758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
